Advancing Intestinal Organoid Technology Toward Regenerative Medicine

Tetsuya Nakamura, Toshiro Sato

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

With the emergence of technologies to culture intestinal epithelial cells in vitro as various forms of intestinal organoids, there is growing interest in using such cultured intestinal cells as a source for tissue engineering and regenerative medicine. One such approach would be to combine the organoid technology with methodologies to engineer the culture environment, particularly the three-dimensional scaffold materials, to generate intestines that exquisitely recapitulate their original structures and functions. Another approach to use organoids for regenerative medicine would be to urge them to mature into functional intestines by implanting them into hosts. This process includes the tissue-engineered small intestine that uses synthetic scaffolds for tissue regeneration and direct organoid transplantation that takes advantage of submucosal tissues in the native intestines as a scaffold. Further study in these subfields could lead to the development of therapeutic options to use different types of organoids with various cell types in regenerative medicine for intestinal diseases in humans.

Original languageEnglish
Pages (from-to)51-60
Number of pages10
JournalCMGH
Volume5
Issue number1
DOIs
Publication statusPublished - 2018 Jan 1

Fingerprint

Organoids
Regenerative Medicine
Technology
Intestines
Tissue Scaffolds
Intestinal Diseases
Tissue Engineering
Small Intestine
Regeneration
Cultured Cells
Transplantation
Epithelial Cells

Keywords

  • Intestinal Organoid
  • Intestinal Stem Cells
  • Regenerative Medicine
  • Tissue Engineering
  • Transplantation

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Advancing Intestinal Organoid Technology Toward Regenerative Medicine. / Nakamura, Tetsuya; Sato, Toshiro.

In: CMGH, Vol. 5, No. 1, 01.01.2018, p. 51-60.

Research output: Contribution to journalReview article

Nakamura, Tetsuya ; Sato, Toshiro. / Advancing Intestinal Organoid Technology Toward Regenerative Medicine. In: CMGH. 2018 ; Vol. 5, No. 1. pp. 51-60.
@article{4e590c563693499191e1cbd74a744f79,
title = "Advancing Intestinal Organoid Technology Toward Regenerative Medicine",
abstract = "With the emergence of technologies to culture intestinal epithelial cells in vitro as various forms of intestinal organoids, there is growing interest in using such cultured intestinal cells as a source for tissue engineering and regenerative medicine. One such approach would be to combine the organoid technology with methodologies to engineer the culture environment, particularly the three-dimensional scaffold materials, to generate intestines that exquisitely recapitulate their original structures and functions. Another approach to use organoids for regenerative medicine would be to urge them to mature into functional intestines by implanting them into hosts. This process includes the tissue-engineered small intestine that uses synthetic scaffolds for tissue regeneration and direct organoid transplantation that takes advantage of submucosal tissues in the native intestines as a scaffold. Further study in these subfields could lead to the development of therapeutic options to use different types of organoids with various cell types in regenerative medicine for intestinal diseases in humans.",
keywords = "Intestinal Organoid, Intestinal Stem Cells, Regenerative Medicine, Tissue Engineering, Transplantation",
author = "Tetsuya Nakamura and Toshiro Sato",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jcmgh.2017.10.006",
language = "English",
volume = "5",
pages = "51--60",
journal = "Cellular and Molecular Gastroenterology and Hepatology",
issn = "2352-345X",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Advancing Intestinal Organoid Technology Toward Regenerative Medicine

AU - Nakamura, Tetsuya

AU - Sato, Toshiro

PY - 2018/1/1

Y1 - 2018/1/1

N2 - With the emergence of technologies to culture intestinal epithelial cells in vitro as various forms of intestinal organoids, there is growing interest in using such cultured intestinal cells as a source for tissue engineering and regenerative medicine. One such approach would be to combine the organoid technology with methodologies to engineer the culture environment, particularly the three-dimensional scaffold materials, to generate intestines that exquisitely recapitulate their original structures and functions. Another approach to use organoids for regenerative medicine would be to urge them to mature into functional intestines by implanting them into hosts. This process includes the tissue-engineered small intestine that uses synthetic scaffolds for tissue regeneration and direct organoid transplantation that takes advantage of submucosal tissues in the native intestines as a scaffold. Further study in these subfields could lead to the development of therapeutic options to use different types of organoids with various cell types in regenerative medicine for intestinal diseases in humans.

AB - With the emergence of technologies to culture intestinal epithelial cells in vitro as various forms of intestinal organoids, there is growing interest in using such cultured intestinal cells as a source for tissue engineering and regenerative medicine. One such approach would be to combine the organoid technology with methodologies to engineer the culture environment, particularly the three-dimensional scaffold materials, to generate intestines that exquisitely recapitulate their original structures and functions. Another approach to use organoids for regenerative medicine would be to urge them to mature into functional intestines by implanting them into hosts. This process includes the tissue-engineered small intestine that uses synthetic scaffolds for tissue regeneration and direct organoid transplantation that takes advantage of submucosal tissues in the native intestines as a scaffold. Further study in these subfields could lead to the development of therapeutic options to use different types of organoids with various cell types in regenerative medicine for intestinal diseases in humans.

KW - Intestinal Organoid

KW - Intestinal Stem Cells

KW - Regenerative Medicine

KW - Tissue Engineering

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=85039848412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039848412&partnerID=8YFLogxK

U2 - 10.1016/j.jcmgh.2017.10.006

DO - 10.1016/j.jcmgh.2017.10.006

M3 - Review article

AN - SCOPUS:85039848412

VL - 5

SP - 51

EP - 60

JO - Cellular and Molecular Gastroenterology and Hepatology

JF - Cellular and Molecular Gastroenterology and Hepatology

SN - 2352-345X

IS - 1

ER -